Cargando…

Variable reporting of C9orf72 and a high rate of uncertain results in ALS genetic testing

Detalles Bibliográficos
Autores principales:	Klepek, Holly, Goutman, Stephen A., Quick, Adam, Kolb, Stephen J., Roggenbuck, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340336/ https://www.ncbi.nlm.nih.gov/pubmed/30697590 http://dx.doi.org/10.1212/NXG.0000000000000301

Ejemplares similares

Incidence of pathogenic, likely pathogenic, and uncertain ALS variants in a clinic cohort
por: Roggenbuck, Jennifer, et al.
Publicado: (2020)

C9orf72 and the Care of the Patient With ALS or FTD: Progress and Recommendations After 10 Years
por: Roggenbuck, Jennifer
Publicado: (2020)

White matter lesions in FTLD: distinct phenotypes characterize GRN and C9ORF72 mutations
por: Ameur, Fatima, et al.
Publicado: (2016)

Systemic Capillary Leak Syndrome With Cerebral Involvement in a C9orf72 Expansion Carrier: Case Report and Review of the Literature
por: Sennfält, Stefan, et al.
Publicado: (2023)

ARHGEF28 p.Lys280Metfs40Ter in an amyotrophic lateral sclerosis family with a C9orf72 expansion
por: Farhan, Sali M.K., et al.
Publicado: (2017)

Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD
por: Hukema, Renate K., et al.
Publicado: (2016)

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
por: Sattler, Rita, et al.
Publicado: (2023)

Treatment implications of C9ORF72
por: Sha, Sharon J, et al.
Publicado: (2012)

Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
por: Lorenzini, Ileana, et al.
Publicado: (2023)

C9orf72 intermediate expansions of 24–30 repeats are associated with ALS
por: Iacoangeli, Alfredo, et al.
Publicado: (2019)

RNA Misprocessing in C9orf72-Linked Neurodegeneration
por: Barker, Holly V., et al.
Publicado: (2017)

Translational repression in the pathogenesis of FUS- and C9orf72-dependent ALS
por: Cozzolino, Mauro, et al.
Publicado: (2015)

The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD
por: Freibaum, Brian D., et al.
Publicado: (2017)

Synaptopathy Mechanisms in ALS Caused by C9orf72 Repeat Expansion
por: Nishimura, Agnes L., et al.
Publicado: (2021)

Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
por: Mayl, Keith, et al.
Publicado: (2021)

Breakdown of the central synapses in C9orf72-linked ALS/FTD
por: Ghaffari, Layla T., et al.
Publicado: (2022)

The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs
por: Levine, Timothy P., et al.
Publicado: (2013)

Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
por: Fong, Jamie C, et al.
Publicado: (2012)

Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS
por: Prudencio, Mercedes, et al.
Publicado: (2015)

Structure of the C9orf72 Arf GAP complex haploinsufficient in ALS and FTD
por: Su, Ming-Yuan, et al.
Publicado: (2020)

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
por: Schmitz, Alexander, et al.
Publicado: (2021)

Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients
por: Trojsi, Francesca, et al.
Publicado: (2019)

Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression
por: McGoldrick, Philip, et al.
Publicado: (2018)

Neuroimaging features of C9ORF72 expansion
por: Yokoyama, Jennifer S, et al.
Publicado: (2012)

C9orf72 immunohistochemistry in Alzheimer's disease
por: Hortobágyi, Tibor
Publicado: (2012)

The Enigmatic Role of C9ORF72 in Autophagy
por: Nassif, Melissa, et al.
Publicado: (2017)

Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
por: Liu, Elaine Y., et al.
Publicado: (2020)

Intrafamilial Phenotypic Variability in the C9orf72 Gene Expansion: 2 Case Studies
por: Foxe, David, et al.
Publicado: (2018)

The mouse C9ORF72 ortholog is enriched in neurons known to degenerate in ALS and FTD
por: Suzuki, Naoki, et al.
Publicado: (2013)

Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion
por: Westeneng, Henk-Jan, et al.
Publicado: (2016)

Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients
por: Prudencio, Mercedes, et al.
Publicado: (2017)

C9ORF72 and the FTD-ALS spectrum: A systematic review of neuroimaging studies
por: Prado, Laura de Godoy Rousseff, et al.
Publicado: (2015)

The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS
por: Dafinca, Ruxandra, et al.
Publicado: (2021)

Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains
por: Wang, Qingqing, et al.
Publicado: (2020)

Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
por: Coyne, Alyssa N., et al.
Publicado: (2021)

Hypothesis and Theory: Roles of Arginine Methylation in C9orf72-Mediated ALS and FTD
por: Gill, Anna L., et al.
Publicado: (2021)

C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS
por: Lualdi, Marta, et al.
Publicado: (2021)

Measuring and Interpreting Nuclear Transport in Neurodegenerative Disease—The Example of C9orf72 ALS
por: Semmelink, Marije F. W., et al.
Publicado: (2021)

Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD
por: Solomon, Daniel A., et al.
Publicado: (2021)

HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS
por: Braems, Elke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ubvlkhndd6d26csad9rfrk0476